Rabeprazole Sodium DR
Pre-Solicitation Posted
This opportunity was awarded. See its 2 award notices in the notice history.
- Solicitation number
- SPE2D2-25-R-0006
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. The solicitation will seek a firm-fixed price contract to supply Rabeprazole Sodium DR 20MG in 30, 90, and 500 count bottles for multiple federal agencies including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The acquisition will be fully competitive and unrestricted, processed as a commercial item under FAR Part 12. Interested parties should contact Trong Nguyen at (215-737-4197) or Trong.Nguyen@dla.mil for questions, and can expect the solicitation to be posted on DIBBS and SAM.GOV. The projected solicitation date is February 2025, though DLA reserves the right to adjust this timeline.
The contract will have a one-year base period with four potential one-year option periods, establishing a national supply source for the specified pharmaceutical product. This is an unrestricted procurement with no specific set-aside designations, meaning all qualified sources may submit proposals for consideration. While specific award values are not detailed in the pre-solicitation notice, the contract will be structured to support multiple federal agencies through DLA and VA prime vendor programs. Annual usage estimates will be provided in the Schedule of Supplies within the full solicitation. Vendors are encouraged to set up automated notifications through the procurement websites to stay informed about potential changes or updates to the solicitation process.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. Procurement details follow.
Rabeprazole Sodium DR 20MG in 30, 90 and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual estimated usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.GOV at https://sam.gov/. Interested parties should contact Trong Nguyen at (215-737-4197) or email Trong.Nguyen@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is February of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Rabeprazole Sodium DR - Award | Award Notice | |
| Pharm Manuf/Distr Div - FSA | Award Notice | |
| Rabeprazole Sodium DR | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity